Danish pharma company says Eli Lilly using outdated trial data to make its weight-loss drugs appear more effective
Ozempic maker Novo Nordisk said on Tuesday it is suing arch US rival Eli Lilly over “…
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Danish group claims rival used outdated data to support claims that its products were more effective than Wegovy